vs
Side-by-side financial comparison of Magnolia Oil & Gas Corp (MGY) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $317.6M, roughly 2.0× Magnolia Oil & Gas Corp). Royalty Pharma plc runs the higher net margin — 34.4% vs 21.6%, a 12.8% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -2.7%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -0.3%).
Imperial Oil Limited is a Canadian petroleum company. It is Canada's second-largest integrated oil company that is also occasionally known as Imperial Esso. It is majority-owned by American oil company ExxonMobil, with a 69.6% ownership stake in the company. It is a producer of crude oil, diluted bitumen, and natural gas. Imperial Oil is one of Canada's major petroleum refiners and petrochemical producers. It supplies Esso-brand service stations.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
MGY vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $317.6M | $622.0M |
| Net Profit | $68.8M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | 29.6% | 62.4% |
| Net Margin | 21.6% | 34.4% |
| Revenue YoY | -2.7% | 4.8% |
| Net Profit YoY | -19.7% | 2.9% |
| EPS (diluted) | — | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $317.6M | $622.0M | ||
| Q3 25 | $324.9M | $609.3M | ||
| Q2 25 | $319.0M | $578.7M | ||
| Q1 25 | $350.3M | $568.2M | ||
| Q4 24 | $326.6M | $593.6M | ||
| Q3 24 | $333.1M | $564.7M | ||
| Q2 24 | $336.7M | $537.3M | ||
| Q1 24 | $319.4M | $568.0M |
| Q4 25 | $68.8M | $214.2M | ||
| Q3 25 | $75.5M | $288.2M | ||
| Q2 25 | $78.1M | $30.2M | ||
| Q1 25 | $102.9M | $238.3M | ||
| Q4 24 | $85.6M | $208.2M | ||
| Q3 24 | $99.8M | $544.0M | ||
| Q2 24 | $95.6M | $102.0M | ||
| Q1 24 | $85.1M | $4.8M |
| Q4 25 | 29.6% | 62.4% | ||
| Q3 25 | 31.2% | 70.1% | ||
| Q2 25 | 33.8% | 36.3% | ||
| Q1 25 | 38.8% | 94.0% | ||
| Q4 24 | 38.0% | 60.9% | ||
| Q3 24 | 38.7% | — | ||
| Q2 24 | 39.9% | 50.2% | ||
| Q1 24 | 39.0% | -13.0% |
| Q4 25 | 21.6% | 34.4% | ||
| Q3 25 | 23.2% | 47.3% | ||
| Q2 25 | 24.5% | 5.2% | ||
| Q1 25 | 29.4% | 41.9% | ||
| Q4 24 | 26.2% | 35.1% | ||
| Q3 24 | 30.0% | 96.3% | ||
| Q2 24 | 28.4% | 19.0% | ||
| Q1 24 | 26.6% | 0.8% |
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $266.8M | $618.7M |
| Total DebtLower is stronger | $393.3M | $9.0B |
| Stockholders' EquityBook value | $2.0B | $9.7B |
| Total Assets | $2.9B | $19.6B |
| Debt / EquityLower = less leverage | 0.20× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $266.8M | $618.7M | ||
| Q3 25 | $280.5M | $938.9M | ||
| Q2 25 | $251.8M | $631.9M | ||
| Q1 25 | $247.6M | $1.1B | ||
| Q4 24 | $260.0M | $929.0M | ||
| Q3 24 | $276.1M | $950.1M | ||
| Q2 24 | $275.7M | $1.8B | ||
| Q1 24 | $399.3M | $843.0M |
| Q4 25 | $393.3M | $9.0B | ||
| Q3 25 | $393.1M | $8.9B | ||
| Q2 25 | $392.9M | $8.0B | ||
| Q1 25 | $392.7M | $7.6B | ||
| Q4 24 | $392.5M | $7.6B | ||
| Q3 24 | $394.8M | $7.6B | ||
| Q2 24 | $394.1M | $7.6B | ||
| Q1 24 | $393.5M | $6.1B |
| Q4 25 | $2.0B | $9.7B | ||
| Q3 25 | $2.0B | $9.6B | ||
| Q2 25 | $2.0B | $9.5B | ||
| Q1 25 | $2.0B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $2.0B | $10.3B | ||
| Q2 24 | $1.9B | $9.8B | ||
| Q1 24 | $1.9B | $9.9B |
| Q4 25 | $2.9B | $19.6B | ||
| Q3 25 | $2.9B | $19.3B | ||
| Q2 25 | $2.9B | $18.3B | ||
| Q1 25 | $2.9B | $17.6B | ||
| Q4 24 | $2.8B | $18.2B | ||
| Q3 24 | $2.8B | $18.0B | ||
| Q2 24 | $2.8B | $17.7B | ||
| Q1 24 | $2.8B | $16.1B |
| Q4 25 | 0.20× | 0.92× | ||
| Q3 25 | 0.20× | 0.93× | ||
| Q2 25 | 0.20× | 0.84× | ||
| Q1 25 | 0.20× | 0.78× | ||
| Q4 24 | 0.20× | 0.74× | ||
| Q3 24 | 0.20× | 0.74× | ||
| Q2 24 | 0.21× | 0.78× | ||
| Q1 24 | 0.21× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $208.4M | $827.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.03× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $208.4M | $827.1M | ||
| Q3 25 | $247.1M | $702.6M | ||
| Q2 25 | $198.7M | $364.0M | ||
| Q1 25 | $224.5M | $596.1M | ||
| Q4 24 | $222.6M | $742.5M | ||
| Q3 24 | $217.9M | $703.6M | ||
| Q2 24 | $269.4M | $658.2M | ||
| Q1 24 | $210.9M | $664.6M |
| Q4 25 | 3.03× | 3.86× | ||
| Q3 25 | 3.27× | 2.44× | ||
| Q2 25 | 2.54× | 12.06× | ||
| Q1 25 | 2.18× | 2.50× | ||
| Q4 24 | 2.60× | 3.57× | ||
| Q3 24 | 2.18× | 1.29× | ||
| Q2 24 | 2.82× | 6.45× | ||
| Q1 24 | 2.48× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGY
| Oil And Condensate | $215.6M | 68% |
| Natural Gas Reserves | $52.9M | 17% |
| Natural Gas Liquids Reserves | $49.1M | 15% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
